Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2018 · 10-Q
Revenue$660.00K$660.00K−31.9% vs Q2 2017 Net Income-$3.66M-$3.66MN/M vs Q2 2017 EPS Diluted-$29.67-$29.67N/M vs Q2 2017 Gross Profit$30,000−88.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,721,000N/M Free Cash Flowderived-$2,746,000N/M Margins · derivedGross margin4.5%−22.5 pt vs Q2 2017
Operating margin-279.7%+296.3 pt vs Q2 2017
Net margin-554.4%+69.9 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end